发明名称 FORMULATIONS AND METHODS FOR THE TREATMENT OR PROPHYLAXIS OF PRE-MCI AND/OR PRE-ALZHEIMER'S CONDITIONS
摘要 In certain embodiments the methods of preventing or delaying the onset of a pre-Alzheimer's condition and/or cognitive dysfunction, and/or ameliorating one or more symptoms of a pre-Alzheimer's cognitive dysfunction, and/or preventing or delaying the progression of a pre-Alzheimer's condition or cognitive dysfunction to Alzheimer's disease, and/or of promoting the processing of amyloid precursor protein (APP) by the non-amyloidogenic pathway are provided. In certain embodiments the methods involve administering, or causing to be administered, to a subject in need thereof certain formulations comprising or more active agent(s) selected from the group consisting of tropisetron disulfiram, honokiol, nimetazepam, and/or derivatives or analogs thereof.
申请公布号 US2015030683(A1) 申请公布日期 2015.01.29
申请号 US201314378950 申请日期 2013.02.15
申请人 BUCK INSTITUTE FOR RESEARCH ON AGING 发明人 John Varghese;Bredesen Dale E.;Tzannis Stelios
分类号 A61K31/439;A61K47/48;A61K31/5513;A61K31/145;A61K31/05 主分类号 A61K31/439
代理机构 代理人
主权项 1. A prolonged release drug dosage formulation for peroral or oral transmucosal administration comprising a dissolvable drug formulation wherein said formulation comprises: a predetermined amount of one or more active agent(s) selected from the group consisting of tropisetron disulfiram, honokiol, nimetazepam, and/or derivatives or analogs thereof; and a bioadhesive material, said bioadhesive material providing for adherence to the mucosal membranes of a subject.
地址 NOVATO CA US